Levodopa

immunoglobulin kappa variable 2D-29 ; Homo sapiens







4 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 24687255 Adenosine A2A receptor antagonists in Parkinson's disease: progress in clinical trials from the newly approved istradefylline to drugs in early development and those already discontinued. 2014 May 1
2 23917951 Non-dopaminergic treatments for motor control in Parkinson's disease. 2013 Sep 1
3 16765381 Experimental studies and theoretical aspects on A2A/D2 receptor interactions in a model of Parkinson's disease. Relevance for L-dopa induced dyskinesias. 2006 Oct 25 1
4 16867213 ST 1535: a preferential A2A adenosine receptor antagonist. 2006 Oct 1